Even if the lazy cash doesn't find an opportunity for expansion it should be at least a 10 bragger. All its Chinese company piers are trading at more than 8 X earnings.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential